Q3 financial results are in. With unwavering dedication to advancing Afib treatment options and enhancing post-operative patient care, we have continued to expand our product portfolio and global reach. Read the earnings report at:: <a href="https://t.co/aeBPb9Aar6&quot; target="_blank">https://t.co/aeBPb9Aar6</a&gt;
<a href="https://twitter.com/hashtag/earnings?src=hashtag_click&quot; target="_blank">#earnings</a>